Market Review for Monday, December 22, 2025
Shared by Stephen
• December 23, 2025
Hi there,
Overview: All three major US indices finished higher as the market entered a relatively calm holiday week. The S&P 500 and Dow Jones are now both within 1% of their record closing levels. Geopolitical tensions in the Caribbean and Eastern Europe drove oil and precious metals to fresh heights.
📈 Major Indices
-
S&P 500: Rose +0.64%, closing at 6,878.49.
-
Nasdaq Composite: Gained +0.52%, ending at 23,428.83.
-
Dow Jones Industrial Average: Added +0.47%, closing at 48,362.68.
-
Russell 2000: Outpaced large caps with a +1.2% gain.
🏛️ Bonds, FX & Commodities
-
US 10-Year Yield: Rose to 4.17% (from Friday's 4.14%), marking its highest level in a week as investors balanced global central bank signals.
-
US Dollar Index (DXY): Eased -0.3% to 98.28.
-
Gold: Surged nearly +2% to set a new all-time record high of $4,475.40.
-
Silver: Also hit a fresh record, climbing to roughly $68.85 per ounce.
-
WTI Crude Oil: Jumped +2.6% to settle near $58.01 per barrel on rising U.S.-Venezuela tensions and a tanker "blockade."
📊 Specific Stock Performance
-
GOOGL (Alphabet Inc.): Up +1.2% (approx. $317.02). Benefited from news regarding its acquisition of Intersect to expand data center power capacity.
-
META (Meta Platforms): Up +0.9% (approx. $678.61). Continued to drift higher alongside mega-cap tech peers in light holiday trading.
-
FLTR.L (Flutter Entertainment): Down -0.45% (16,445.00p). Saw minor profit-taking in the London session after a strong close to the previous week.
-
ALK (Alaska Air Group): Up +1.25% ($52.25). Gained as the broader industrial sector provided a strong push to the Dow and S&P.
-
PFE (Pfizer Inc.): Up +0.35% ($25.27). A quiet but positive session as value stocks caught a minor bid.
-
STZ (Constellation Brands): Up +0.15% ($135.50). Stabilized after recent weakness, though it still lagged the broader market rally.
-
NVO (Novo Nordisk ADR): Up +0.02% ($48.10). Remained flat during the main session but saw a significant jump in post-market trading (+$4.54) following news of FDA approval for a new GLP-1 pill form.
📞 Strategy Call Assistance
If you require assistance with trade setup, risk management, or strategy review, please schedule a strategy call.
-
PREMIUM Plan Members: Strategy calls are included in your plan.
-
All Other Members: Strategy calls can be scheduled at a rate of €100 per half hour.
Happy Investing
Share Navigator Support
www.sharenavigator.ie